|
|
Volumn 291, Issue 24, 2004, Pages
|
|
Breast cancer gene chip study under way: Can new technology help predict treatment success?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANASTROZOLE;
TAMOXIFEN;
BREAST CANCER;
CANCER ADJUVANT THERAPY;
CANCER HORMONE THERAPY;
CANCER RECURRENCE;
CANCER RESEARCH;
CANCER THERAPY;
CLINICAL TRIAL;
DNA MICROARRAY;
EUROPE;
FINANCIAL MANAGEMENT;
GENE EXPRESSION PROFILING;
HUMAN;
MEDICAL TECHNOLOGY;
PATIENT SELECTION;
PREDICTION;
PRIORITY JOURNAL;
PROGNOSIS;
RECURRENCE RISK;
REVIEW;
SOUTH AND CENTRAL AMERICA;
TREATMENT OUTCOME;
ARTICLE;
BREAST TUMOR;
CONTROLLED CLINICAL TRIAL;
FEMALE;
GENETICS;
RANDOMIZED CONTROLLED TRIAL;
BREAST NEOPLASMS;
FEMALE;
GENE EXPRESSION PROFILING;
HUMANS;
OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIALS;
|
|
EID: 2942703919
PISSN: 00987484
EISSN: None
Source Type: Journal
DOI: 10.1001/jama.291.24.2927 Document Type: Review |
|
Times cited : (6)
|
|
References (0)
|